CME Group Inc. Cl A stock falls 1.09% and underperforms competitors

8 articles · Updated · MarketWatch · Apr 27

Shares closed at $281.94 on Monday, marking a third straight day of losses and finishing 14.35% below the 52-week high of $329.16 set on March 3.
The stock's decline came during a mixed market session, with the S&P 500 rising 0.12% and the Dow Jones falling 0.13%.
CME Group's performance contrasted with competitors, as Intercontinental Exchange fell 0.95%, Nasdaq rose 0.59%, and Cboe Global Markets dropped 1.77%.

As CME's stock dips, will its bold crypto expansion and new 'CME Coin' revive its market value?

Following recent SEC guidance, what hurdles remain for CME’s planned 24/7 crypto derivatives market?

Will CME’s new cross-margining with FICC truly stabilize the U.S. Treasury market as intended?

With a historic M&A wave predicted for 2026, is CME a potential target in the exchange wars?

CME is betting $1.2B on new technology. Can this investment shield it from rising cybersecurity threats?

Are major banks bypassing central clearing, secretly increasing systemic risk despite post-2008 reforms?